logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories enter into agreement with Swedish region

Investor News 2025-01-08
Inify Laboratories, a unique laboratory service that performs cancer diagnostics within pathology, has entered into an agreement with the region of Västmanland in Sweden on a pilot project with the […]
Read More

Inify Laboratories – Registration of prospectus and upcoming launch of Subsequent Offering

Investor News 2025-01-07
 STOCKHOLM – 7 January 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company“) on 16 December 2024 regarding the successful private placement […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2024-12-16
Stockholm, Sweden, December 16, 2024; Inify Laboratories AB (publ.) announces that the below primary insider was allocated new shares at the Offer Price in the Private Placement as further specified […]
Read More

Inify Laboratories: Key information regarding potential Subsequent Offering

Investor News 2024-12-16
Reference is made to the stock exchange announcement published today, 16 December 2024, regarding the successful private placement of 30,202,366 new shares (the “Private Placement”) in Inify Laboratories AB (publ) […]
Read More

Inify Laboratories announces successful placement of fully guaranteed private placement

Investor News 2024-12-16
STOCKHOLM – 16 December 2024 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 9 December 2024 regarding the board of directors' […]
Read More

Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue

Investor News 2024-12-09
STOCKHOLM – 9 December 2024 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company”) on 15 November 2024, regarding a proposed fully guaranteed […]
Read More

Inify Laboratories AB (publ) – Bulletin from the extraordinary general meeting

Annual General Meeting, Investor News 2024-12-06
Today, December 6, 2024, INIFY Laboratories AB, org. no. 559345-4431 (the "Company") held an extraordinary general meeting. A total of 28,168,336 shares were represented at the general meeting, which corresponds […]
Read More

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million

Annual General Meeting, Investor News 2024-11-15
STOCKHOLM – November 15, 2024 – reference is made to the stock exchange announcement made by Inify Laboratories AB (“Inify” or the “Company”) on 23 October 2024 regarding expansion to […]
Read More

Inify Laboratories – notice of Extraordinary General Meeting on December 6, 2024

Annual General Meeting, Investor News 2024-11-15
Stockholm – November 15, 2024 – Inify Laboratories AB (publ), a unique laboratory service provider within pathology and cancer diagnostics, hereby invites its shareholders to Extraordinary General Meeting on December […]
Read More

Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer

Investor News, News 2024-11-05
STOCKHOLM – November 05, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, is proud to announce a partnership with the ProMort research team at […]
Read More
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9

  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calendar

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories